TABLE 1.
Demographic data | |
Number of patients | 128 |
Females | 116/128 (91%) |
Height in cm | 172 (8) |
Weight in kg | 75 (17) |
Age in years | 39 (11) |
Median duration of ME/CFS (IQR) in years | 9 (5–16) |
Disease severity: mild/moderate/severe* | 49/55/24 (38%/43%/19%) |
Fibromyalgia present | 65/128 (51%) |
Self-reported cognitive problems | 108/128 (84%) |
SSRI use | 34/128 (27%) |
Hemodynamic responses during HUT | |
Normal heart rate/blood pressure response | 59/128 (46%) |
Postural orthostatic tachycardia syndrome (POTS) | 49/128 (38%) |
Orthostatic hypotension (OH) | 20/128 (16%) |
Data represent mean (SD). HUT: head-up tilt test; SSRI: selective serotonin reuptake inhibitors. *Disease severity grading according to classification of ICC (Carruthers et al., 2011).